Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
about
Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasoundReal-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinomaComparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular CarcinomaCurrent consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.Targeted renal therapies through microbubbles and ultrasound.Contrast enhanced ultrasound of hepatocellular carcinoma.Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinomaDetection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studiesThe Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation.Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancerCT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonographyAdvancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma.Diagnostic imaging of hepatocellular carcinoma: recent progress.Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.Radiofrequency ablation of liver metastases from colorectal cancer: a literature reviewContrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions.Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography.Ongoing challenges in the diagnosis of hepatocellular carcinoma.Breakthrough Imaging in Hepatocellular CarcinomaValue of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.Hepatic malignancies: Correlation between sonographic findings and pathological features.An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.Utility of contrast-enhanced ultrasonography for qualitative imaging of atherosclerosis in Watanabe heritable hyperlipidemic rabbits: initial experimental study.Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.Contrast-enhanced ultrasound in liver cancerUsefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tom
P2860
Q27005624-08F32CB1-5E3D-4216-98D7-8642CC28E008Q27012775-B5490A83-5C55-4FE6-A270-09E4D83C681DQ30359316-016358BA-A015-445C-AA24-BF464CCDB559Q30388235-13FC1F1A-E670-4FF6-80CC-2271E9D56299Q30455431-360ACADE-4DC9-4FFD-B7D6-48183CA780D0Q30462259-EEFA5E48-BCD9-4648-93EE-62FECD28E4E8Q30472126-03C25586-787F-4FAF-90B5-CC6A7F5A4706Q30472688-D2731D6A-0427-4F8F-B11A-F68549E3BCD7Q30478156-93822611-F103-4232-BBF1-33BCF7EE7CEEQ30478164-B735E75B-33C4-4A2A-B647-6095985F4971Q30478166-5FAFD63E-0A60-4C6A-A983-8E81A90594A2Q30479629-613C420B-66BD-4C44-A942-C5564AA99526Q33830708-9F52F2EC-9DF0-4CD0-B8A0-033FEF8F3E8CQ34826535-DB6C6797-2199-46D1-9F25-99DECA3B9C36Q35902261-C53BFE62-B111-473F-88A8-63F1A9CCBA73Q36637298-8A1DE95E-78AB-42CC-9BBA-A285721AB10BQ37072699-496E2645-3710-47E8-93B8-D87BD155B23FQ37168531-85ABA05D-2755-4904-B62C-DECBC58FC3BCQ37646457-969FF2BF-32F1-430A-81AC-15082572688AQ37972809-38103856-A237-4D05-AD1F-EF4F6FF73FEEQ38054740-31E1BC31-5F1D-4DFA-88AE-BDD158EA083FQ38082982-0F34C68B-1E37-4D17-976D-FD1191C6C8E7Q38112750-AC07B3F7-9843-4FA9-AB85-6298B015EC22Q38114077-7D36E5D0-2FD5-4CE5-8227-6C13DB7BF56FQ38646886-0B8F4ADE-A7F7-4FBA-AA90-AC19265341ACQ38969727-8DCC73A1-E4EA-4E26-9A6A-A9AF2154BEE0Q39167641-3186E243-2BA2-43AE-BBCC-2182504AFEFDQ41126839-C349AC9A-D4B6-45BC-8911-F6D8B18BE47EQ41678118-39FDCA2E-3C71-4FFC-97D5-4EBCD63B3FBAQ41962614-B01A0B29-5808-41AF-908B-12334BD575CEQ43171014-34C20512-E3AD-4619-893C-A7BBC975C0A7Q48244144-2A061A3A-B7F8-4EFA-8E0A-B34D9288FAF6Q48265468-919DA607-7D5D-43F4-8253-0890F1F70589Q50969554-3E99C3ED-0B7C-4DD9-894E-149938283866Q51541140-F7034BE0-090E-40A7-81D0-F18F2B3A47F2Q51741309-77F8F8A1-EF87-4FC9-8327-0CA72BFFF088Q53258247-C9F4434C-4394-4A2B-A943-15BDFDDA22C5Q53362427-FCC3949A-2391-4EED-AF6F-CECB2B6F4AA0Q57653509-E0C286A4-4DB7-4E71-8677-F79BF7B982B8Q57763286-426278AF-1CC5-4EFB-8ED4-50DA0A83DDA3
P2860
Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@en
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@nl
type
label
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@en
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@nl
prefLabel
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@en
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@nl
P2093
P2860
P356
P1433
P1476
Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.
@en
P2093
Chie Tatsumi
Hobyung Chung
Kazuomi Ueshima
Kinuyo Hatanaka
Kiyoshi Maekawa
Satoru Hagiwara
Satoshi Kitai
Shunsuke Takahashi
Taisuke Ueda
Tatsuo Inoue
P2860
P356
10.1159/000122600
P478
51 Suppl 1
P577
2008-06-10T00:00:00Z